posteditor

posteditor

INOVIO Announces Proposed Public Offering

B PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ — INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to… Login to continue reading Login Sign up for complimentary access Sign Up Now Close